These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29781879)

  • 1. Cognitive Burden of Common Non-antiretroviral Medications in HIV-Infected Women.
    Rubin LH; Radtke KK; Eum S; Tamraz B; Kumanan KN; Springer G; Maki PM; Anastos K; Merenstein D; Karim R; Weber KM; Gustafson D; Greenblatt RM; Bishop JR
    J Acquir Immune Defic Syndr; 2018 Sep; 79(1):83-91. PubMed ID: 29781879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study.
    Radtke KK; Bacchetti P; Anastos K; Merenstein D; Crystal H; Karim R; Weber KM; Edmonds A; Sheth AN; Fischl MA; Vance D; Greenblatt RM; Rubin LH
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):202-208. PubMed ID: 29762344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
    Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
    J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Cognition Predicts Falls Among Women With and Without HIV Infection.
    Sharma A; Vance DE; Hoover DR; Shi Q; Yin MT; Holman S; Plankey MW; Tien PC; Weber KM; Floris-Moore M; Bolivar HH; Golub ET; McDonnell Holstad M; Rubin LH
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):301-309. PubMed ID: 31913989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.
    Tannenbaum C; Paquette A; Hilmer S; Holroyd-Leduc J; Carnahan R
    Drugs Aging; 2012 Aug; 29(8):639-58. PubMed ID: 22812538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between Antiretrovirals and Cognitive Function in Women with HIV.
    Rubin LH; Li Y; Fitzgerald KC; Dastgheyb R; Spence AB; Maki PM; Sharma A; Gustafson DR; Milam J; Weber KM; Adimora AA; Haughey NJ; Ofotokun I; Fischl MA; Konkle-Parker D; Xu Y; Williams DW
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):195-206. PubMed ID: 32212091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Joshi YB; Thomas ML; Braff DL; Green MF; Gur RC; Gur RE; Nuechterlein KH; Stone WS; Greenwood TA; Lazzeroni LC; MacDonald LR; Molina JL; Nungaray JA; Radant AD; Silverman JM; Sprock J; Sugar CA; Tsuang DW; Tsuang MT; Turetsky BI; Swerdlow NR; Light GA
    Am J Psychiatry; 2021 Sep; 178(9):838-847. PubMed ID: 33985348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degree of Polypharmacy and Cognitive Function in Older Women with HIV.
    Rubin LH; Neijna AG; Shi Q; Hoover DR; Tamraz B; Anastos K; Edmonds A; Fischl MA; Gustafson D; Maki PM; Merenstein D; Sheth AN; Springer G; Vance D; Weber KM; Sharma A
    AIDS Res Hum Retroviruses; 2022 Jul; 38(7):571-579. PubMed ID: 35357949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived and post-traumatic stress are associated with decreased learning, memory, and fluency in HIV-infected women.
    Rubin LH; Cook JA; Springer G; Weber KM; Cohen MH; Martin EM; Valcour VG; Benning L; Alden C; Milam J; Anastos K; Young MA; Gustafson DR; Sundermann EE; Maki PM
    AIDS; 2017 Nov; 31(17):2393-1401. PubMed ID: 28857823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of self-reported prescription opioid use by HIV-positive individuals.
    Turner AN; Maierhofer C; Funderburg NT; Snyder B; Small K; Clark J; Bazan JA; Kwiek NC; Kwiek JJ
    AIDS Care; 2016 Dec; 28(12):1559-1565. PubMed ID: 27320493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study.
    De Vreese LP; Mantesso U; De Bastiani E; Marangoni A; Weger E; Gomiero T
    PLoS One; 2018; 13(10):e0205897. PubMed ID: 30379948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San Francisco.
    Jeevanjee S; Penko J; Guzman D; Miaskowski C; Bangsberg DR; Kushel MB
    AIDS Behav; 2014 Jul; 18(7):1352-8. PubMed ID: 24077929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women.
    Yi T; Cocohoba J; Cohen M; Anastos K; DeHovitz JA; Kono N; Hanna DB; Hessol NA
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):253-62. PubMed ID: 21239994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected women.
    Rubin LH; Sundermann EE; Cook JA; Martin EM; Golub ET; Weber KM; Cohen MH; Crystal H; Cederbaum JA; Anastos K; Young M; Greenblatt RM; Maki PM
    Menopause; 2014 Sep; 21(9):997-1006. PubMed ID: 24496085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
    Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
    J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Depressive Symptoms Are a Stronger Predictor of Executive Dysfunction in HIV-Infected Women Than in Men.
    Rubin LH; Springer G; Martin EM; Seaberg EC; Sacktor NC; Levine A; Valcour VG; Young MA; Becker JT; Maki PM
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):274-283. PubMed ID: 30893126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.